0.1182

2.07% 0.0024

Tnf Pharmaceuticals Inc (TNFA)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$0.1158

Offen:

$0.1123

24-Stunden-Volumen:

3.41M

Relative Volume:

0.91

Marktkapitalisierung:

$2.50M

Einnahmen:

Nettoeinkommen (Verlust:

$-23.66M

KGV:

-0.00854

EPS:

-13.84

Netto-Cashflow:

$-10.14M

1W Leistung:

-5.82%

1M Leistung:

-29.56%

6M Leistung:

-90.07%

1J Leistung:

+0.00%

1-Tages-Spanne:

$0.1123

$0.125

1-Wochen-Bereich:

$0.1008

$0.1334

52-Wochen-Spanne:

$0.1008

$2.16

Tnf Pharmaceuticals Inc Stock (TNFA) Company Profile

Firmenname

Tnf Pharmaceuticals Inc

Sektor

Healthcare (1160)

Branche

Biotechnology (651)

Telefon

856-848-8698

Adresse

1185 AVENUE OF THE AMERICAS, NEW YORK

Mitarbeiter

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

TNFA's Discussions on Twitter

Vergleichen Sie TNFA mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TNFA Tnf Pharmaceuticals Inc	0.1182	2.50M	0	-23.66M	-10.14M	-13.84
VRTX Vertex Pharmaceuticals Inc	459.62	115.95B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	547.36	56.52B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	331.91	39.44B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	543.48	35.14B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	245.49	28.51B	3.81B	-644.79M	-669.77M	-6.24

Tnf Pharmaceuticals Inc Aktie (TNFA) Neueste Nachrichten

Jun 06, 2025

TNF Pharmaceuticals Approves Stock Amendment at Annual Meeting - TipRanks

Jun 06, 2025

Jun 02, 2025

Analyzing TNF Pharmaceuticals (NASDAQ:TNFA) & Aspira Women’s Health (NASDAQ:AWH) - Defense World

Jun 02, 2025

May 22, 2025

Wells Fargo & Company Has Lowered Expectations for Xenon Pharmaceuticals (NASDAQ:XENE) Stock Price - Defense World

May 15, 2025

May 10, 2025

TNF Pharmaceuticals amends bylaws to change voting requirements By Investing.com - Investing.com Nigeria

May 10, 2025

May 09, 2025

TNF Pharmaceuticals amends bylaws to change voting requirements - Investing.com

May 09, 2025

TNF Pharmaceuticals Amends Bylaws to Alter Voting Rules - TipRanks

May 09, 2025

TNF Pharmaceuticals announces promising study results By Investing.com - Investing.com Nigeria

May 09, 2025

May 08, 2025

TNF Pharmaceuticals announces promising study results - Investing.com Australia

May 08, 2025

TNF Pharmaceuticals and Renova Health Report Positive Results in Identifying Targets for Treating TNF-Driven Inflammation in Patients Receiving GLP-1 Agonists - Business Wire

May 08, 2025

Apr 30, 2025

A new trading data show TNF Pharmaceuticals Inc (TNFA) is showing positive returns. - Sete News

Apr 30, 2025

Let’s Jump Into The Magnite Inc (NASDAQ: MGNI) Stock Forecast - Marketing Sentinel

Apr 30, 2025

Apr 28, 2025

TNF Pharmaceuticals Inc Inc. (TNFA) Price Performance: A Guide to Financial Ratios - investchronicle.com

Apr 28, 2025

Is TNF Pharmaceuticals Inc (TNFA) worth investing in despite its overvalued state? - uspostnews.com

Apr 28, 2025

Apr 26, 2025

Gaining Ground: TNF Pharmaceuticals Inc (TNFA) Closes Lower at 0.25, Down -9.00 - DWinneX

Apr 26, 2025

Comparing TNF Pharmaceuticals (NASDAQ:TNFA) & Oruka Therapeutics (NASDAQ:ORKA) - Defense World

Apr 26, 2025

Apr 25, 2025

TNF Pharmaceuticals Inc (NASDAQ:TNFA) Is Looking Good Over The Long Term, Dropped Nearly -46.01% Over A Month. – Marketing Sentinel - Marketing Sentinel

Apr 25, 2025

Apr 24, 2025

Sarcopenia Clinical Trial Pipeline Appears Robust With 18+ - GlobeNewswire

Apr 24, 2025

Sarcopenia Clinical Trial Pipeline Appears Robust With 18+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - GlobeNewswire Inc.

Apr 24, 2025

Apr 23, 2025